Finally, the observation that a biophysical signal from the ECM can modulate tumor cell differentiation has implications beyond neuroblastoma, as N-Myc overexpression can contribute to the pathophysiology of other cancers, such as retinoblastoma, small cell lung carcinoma, and glioblastoma [48]. The gene discussed is MYCN; the disease is neoplasm.